Literature DB >> 10856382

Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study).

S M Haffner1, R D Agostino, M F Saad, D H O'Leary, P J Savage, M Rewers, J Selby, R N Bergman, L Mykkänen.   

Abstract

Type-2 diabetes mellitus is associated with a 2- to 4-fold increase in the risk of clinical coronary artery disease (CAD). It has been suggested that diabetic subjects without clinical CAD should be treated as aggressively for cardiovascular risk factors as subjects with CAD. This would be warranted if diabetic subjects without clinical CAD would have accelerated CAD similar to that of nondiabetic subjects with symptomatic CAD. To assess this suggestion, we compared the intima-media wall thickness in the common carotid artery (CCA) and internal carotid artery (ICA) in 43 diabetic subjects with clinical CAD, 446 diabetic subjects without clinical CAD, 47 nondiabetic subjects with clinical CAD, and 975 nondiabetic subjects without clinical CAD (all aged 40 to 70 years) in the Insulin Resistance Atherosclerosis Study. All data were adjusted for age, gender, ethnicity, and clinical results. Both diabetes and CAD were associated with increased atherosclerosis in the CCA. Likewise, diabetes was significantly associated with increased atherosclerosis in the ICA; however, CAD was not associated with ICA intima-media wall thickness. As expected, diabetic subjects with CAD had the greatest intima-media wall thickness, whereas nondiabetic subjects without CAD had the least atherosclerosis. Subjects with diabetes but without CAD had slightly greater intima-media wall thickness than nondiabetic subjects with CAD, although these differences were not statistically significant. Thus, diabetic subjects even without CAD had extensive atherosclerosis in the carotid artery. These results support the suggestion that diabetic subjects should be treated as aggressively for cardiovascular risk factor management as subjects with pre-existing CAD.

Entities:  

Mesh:

Year:  2000        PMID: 10856382     DOI: 10.1016/s0002-9149(00)00784-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

1.  Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

Authors:  Ruth McPherson; Jiri Frohlich; George Fodor; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 2.  Statins and the prevention of stroke in diabetes.

Authors:  Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

3.  Maternal effect and familial aggregation in a type 2 diabetic Moroccan population.

Authors:  Houda Benrahma; Imen Arfa; Majida Charif; Safaa Bounaceur; Abdelmajid Eloualid; Redouane Boulouiz; Halima Nahili; Omar Abidi; Hassan Rouba; Asmaa Chadli; Mounia Oudghiri; Ahmed Farouqui; Sonia Abdelhak; Abdelhamid Barakat
Journal:  J Community Health       Date:  2011-12

Review 4.  Management of extracranial carotid artery disease.

Authors:  Yinn Cher Ooi; Nestor R Gonzalez
Journal:  Cardiol Clin       Date:  2015-02       Impact factor: 2.213

Review 5.  Serum amyloid A: the "other" inflammatory protein.

Authors:  Kevin D O'Brien; Alan Chait
Journal:  Curr Atheroscler Rep       Date:  2006-01       Impact factor: 5.113

6.  Increased augmentation of central blood pressure is associated with increases in carotid intima-media thickness in type 2 diabetic patients.

Authors:  J Westerbacka; E Leinonen; J T Salonen; R Salonen; A Hiukka; H Yki-Järvinen; M-R Taskinen
Journal:  Diabetologia       Date:  2005-06-23       Impact factor: 10.122

7.  Coronary risk equivalence of diabetes assessed by SPECT-MPI.

Authors:  Donna Chelle V Morales; Sanjeev P Bhavnani; Alan W Ahlberg; Raja C Pullatt; Deborah M Katten; Donna M Polk; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2017-12-06       Impact factor: 5.952

8.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Authors:  David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

9.  Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.

Authors:  Justin M S Lee; Cheerag Shirodaria; Clare E Jackson; Matthew D Robson; Charalambos Antoniades; Jane M Francis; Frank Wiesmann; Keith M Channon; Stefan Neubauer; Robin P Choudhury
Journal:  Diab Vasc Dis Res       Date:  2007-03       Impact factor: 3.291

10.  CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells.

Authors:  Irina N Baranova; Alexander V Bocharov; Tatyana G Vishnyakova; Roger Kurlander; Zhigang Chen; Dong Fu; Irwin M Arias; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.